Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India - Multicentric, real-world study.
Singh DV, Agarwal A, Goyal A, Shroff D, Singh J, Kumar P, Reddy RR, Venkatesh R, Narnaware S, Joshi S, Singh DV, Narula R, Joshi A, Agarwal A, Goyal A, Gupta C, Shroff D, Anantharaman G, Singh J, Kumar P, Bawankule P, Reddy RR, Jain R, Venkatesh R, Tiwari R, Sugumar S, Gupta SR, Narnaware S, Joshi S, Choudhary SP; Delhi Retina Forum Study Group.
Singh DV, et al. Among authors: agarwal a.
Indian J Ophthalmol. 2024 Dec 1;72(12):1786-1794. doi: 10.4103/IJO.IJO_757_24. Epub 2024 Nov 29.
Indian J Ophthalmol. 2024.
PMID: 39620667